The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $61.25

Today's change-0.56 -0.91%
Updated June 30 11:54 AM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $61.25

Today's change-0.56 -0.91%
Updated June 30 11:54 AM EDT. Delayed by at least 15 minutes.

AbbVie Inc crosses below 50-day moving average

AbbVie Inc is lower today, dropping (U.S.)$0.56 or 0.91% to (U.S.)$61.25 and crossing below its 50-day moving average. Over the last five days, shares are unchanged, but have gained 3.39% over the last year to date. This security has underperformed the S&P 500 by 9.81% during the last year.

Key company metrics

  • Open(U.S.) $61.79
  • Previous close(U.S.) $61.81
  • High(U.S.) $62.02
  • Low(U.S.) $61.14
  • Bid / Ask(U.S.) $61.24 / (U.S.) $61.25
  • YTD % change+3.39%
  • Volume2,294,486
  • Average volume (10-day)8,210,698
  • Average volume (1-month)9,206,452
  • Average volume (3-month)8,081,848
  • 52-week range(U.S.) $45.45 to (U.S.) $71.60
  • Beta1.49
  • Trailing P/E18.35×
  • P/E 1 year forward12.98×
  • Forward PEG0.79×
  • Indicated annual dividend(U.S.) $2.28
  • Dividend yield3.72%
  • Trailing EPS(U.S.) $3.34
Updated June 30 11:54 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.13%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue5,9586,4005,9445,475
Total other revenue--------
Total revenue5,9586,4005,9445,475
Gross profit4,6274,9254,8664,559
Total cost of revenue1,3311,4751,078916
Total operating expense3,6804,2874,0593,623
Selling / general / administrative1,3551,7371,4741,703
Research & development9461,0751,418981
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)490023
Other operating expenses, total--00--
Operating income2,2782,1131,8851,852
Interest income (expense), net non-operating-215-208-207-172
Gain (loss) on sale of assets--------
Other--------
Income before tax1,7761,9241,6471,678
Income after tax1,3541,5171,2391,366
Income tax, total422407408312
Net income1,3541,5171,2391,366
Total adjustments to net income--------
Net income before extra. items1,3541,5171,2391,366
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,3541,5171,2391,366
Inc. avail. to common incl. extra. items1,3541,5171,2391,366
Diluted net income1,3541,5171,2391,366
Dilution adjustment--------
Diluted weighted average shares1,6251,6431,6641,633
Diluted EPS excluding extraordinary itemsvalue per share0.830.920.740.84
Dividends per sharevalue per share0.570.570.510.51
Diluted normalized EPSvalue per share0.860.920.740.85